🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Experimental Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are encouraged to contact these accounts directly for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with numerous of participants share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers promote the drug there before redirecting customers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Voice Worries

However, doctors and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.

Several professionals stated the demand for the experimental drug could be linked to the increasing price of approved slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that must not be marketed or distributed for human use under the British medical regulations.

Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate medicines, advertising, and consumer laws, potentially leading to fines, prosecution or prison.

Platform Response and Material Removal

Based on TikTok, the service has removed violative content and banned related keywords and query recommendations. The organization said it was committed to keeping the platform secure and allocating resources in strengthening compliance measures.

Digital Marketplace Operations

Research also found communities with up to 9,000 participants marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly displays groups with numerous of users, filled with photos of slimming results, glowing reviews and step-by-step guides for preparing or injecting at home.

After moments of joining one community, a vendor shared contact information, where most purchases occur. The vendor sent an guidebook and promised delivery within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or past usage.

Item Information and Costs

Inside these groups, posts show black plastic packages with Royal Mail stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with purified liquid, or pre-filled pens usually sold at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for Telegram said it regularly monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering substances they can’t verify. Even if the science behind retatrutide is valid, these online products may not contain what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has already seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a company investigational substance not yet authorized … may expose patients to potentially serious medical dangers”.